ベータ・ラクタム依存性凝固性陰性スタフィロコクスは,尿路感染症と関連しています
Lancet (London, England)
|October 6, 1999
まとめ
ベータ・ラクタム依存性ステーフィロコーカス・サプロフィティカスは,生存のためにベータ・ラクタム抗生物質を必要とする細菌で,再発性尿路感染症の患者で特定されました. このユニークな依存症は,アモキシチリンを繰り返し投与した後に発生した.
科学分野:
- 微生物学 微生物学とは
- 感染症 感染症は感染症です.
- 薬理学 薬理学とは
背景:
- 再発性尿路感染症 (UTI) は,一般的な臨床的課題です.
- Staphylococcus saprophyticusは,特に若い女性において,尿路感染症の頻繁な病原体である.
- アモキシチリンなどのベータ・ラクタム系抗生物質は,細菌感染症の標準的な治療法です.
研究 の 目的:
- ベータ・ラクタム依存性のスタフィロコッカス・サプロフィティカス菌株の隔離を報告する.
- 尿病原菌における抗生物質依存の潜在的なメカニズムを調査する.
主な方法:
- 中流の尿からバクテリアの分離.
- 抗生物質感受性の検査. 抗生物質感受性の検査.
- バクテリアの成長要件の特徴.
主要な成果:
- 再発性尿路感染症の患者からStaphylococcus saprophyticusを分離した.
- 孤立した株におけるβ-ラクタム依存性の実証.
- 患者は,アモキシチリン治療を繰り返し受けた病歴がありました.
結論:
- ベータ・ラクタム依存症は,Staphylococcus saprophyticus.で発生することがあります.
- この現象は,再発性尿路炎の治療戦略に影響を及ぼす可能性があります.
- 抗生物質依存のメカニズムと臨床的関連性を明らかにするためにさらなる研究が必要です.
関連する概念動画
01:25Urinary Tract Infection II: Pathophysiology
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
01:28Microbiota of the Urogenital Tract
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...